Showing 7,481 - 7,500 results of 7,567 for search '"Crohn's ', query time: 0.20s Refine Results
  1. 7481

    Transcriptome-wide association study identified candidate genes associated with gut microbiota by Chuyu Pan, Yujie Ning, Yumeng Jia, Shiqiang Cheng, Yan Wen, Xuena Yang, Peilin Meng, Chun’e Li, Huijie Zhang, Yujing Chen, Jingxi Zhang, Zhen Zhang, Feng Zhang

    Published 2021-12-01
    “…For instance, SFTPD for an unclassified genus of Proteobacteria was related to atherosclerosis, and FUT2 for Bifidobacterium was associated with Crohn’s disease. Conclusions Our study results provided novel insights for understanding the genetic mechanism of gut microbiota, and attempted to provide clues for revealing the influence of genetic factors on gut microbiota for the occurrence and development of diseases.…”
    Get full text
    Article
  2. 7482

    Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies by Mohammad Shehab, Fatema Alrashed, Ahmad Alfadhli, Khazna Alotaibi, Abdullah Alsahli, Hussain Mohammad, Preethi Cherian, Irina Al-Khairi, Thangavel Alphonse Thanaraj, Arshad Channanath, Hamad Ali, Mohamed Abu-Farha, Jehad Abubaker, Fahd Al-Mulla

    Published 2021-12-01
    “…<b>Results:</b> A total of 126 patients were enrolled (mean age, 31 years; 60% male; 71% Crohn’s disease, 29% ulcerative colitis). Of these, 92 patients were vaccinated with the BNT162b2 vaccine (73%) and 34 patients with the ChAdOx1 nCoV-19 vaccine (27%). …”
    Get full text
    Article
  3. 7483

    Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasisResearch in context by Takahiro Yamada, Shingo Hino, Hideki Iijima, Tomomi Genda, Ryo Aoki, Ryuji Nagata, Kyu-Ho Han, Masato Hirota, Yusuke Kinashi, Hiroyuki Oguchi, Wataru Suda, Yukihiro Furusawa, Yumiko Fujimura, Jun Kunisawa, Masahira Hattori, Michihiro Fukushima, Tatsuya Morita, Koji Hase

    Published 2019-10-01
    “…Methods: To elucidate relationships among dysbiosis, abnormal mucin utilisation, and microbial metabolic dysfunction, we analysed short-chain fatty acids (SCFAs) and mucin components in stool samples of 40 healthy subjects, 49 ulcerative colitis (UC) patients, and 44 Crohn's disease (CD) patients from Japan. Findings: Levels of n-butyrate were significantly lower in stools of both CD and UC patients than in stools of healthy subjects. …”
    Get full text
    Article
  4. 7484

    Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort by Camille Wicker, Célina Roda, Ariane Perry, Jean Baptiste Arnoux, Anais Brassier, Martin Castelle, Aude Servais, Jean Donadieu, Juliette Bouchereau, Bénédicte Pigneur, Philippe Labrune, Frank M. Ruemmele, Pascale de Lonlay

    Published 2020-06-01
    “…Glycogenosis type Ib (GSD1B) causes not only hypoglycemia but also infections and “Crohn's disease like” inflammatory bowel disease (IBD) that can significantly impair patient's quality of life. …”
    Get full text
    Article
  5. 7485
  6. 7486

    Trends in adult Home Parenteral Nutrition in Spain: 1992-2003 Tendencias en nutrición parenteral domiciliaria en pacientes adultos en España: periodo 1992-2003 by J. M. Moreno Villares, C. Cuerda, M. Planas, C. Gómez Candela, M. León-Sanz, A. de Cos, C. Pedrón

    Published 2006-10-01
    “…Excepto el descenso en el número de pacientes con enfermedad de Crohn, el resto de indicaciones sufrió pocas variaciones en el tiempo. …”
    Get full text
    Article
  7. 7487
  8. 7488
  9. 7489

    MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu by Byung-Chul Lee, Byung-Chul Lee, Nari Shin, Nari Shin, Jin Young Lee, Jin Young Lee, Insung Kang, Insung Kang, Jae-Jun Kim, Jae-Jun Kim, Seung Eun Lee, Seung Eun Lee, Soon Won Choi, Soon Won Choi, Gill A. Webster, Kyung-Sun Kang, Kyung-Sun Kang

    Published 2018-05-01
    “…In this study, we investigated whether administration of MIS416, a novel microparticle that activates NOD2 and TLR9 signaling, could enhance the therapeutic efficacy of hUCB-MSCs against Crohn’s disease, using dextran sulfate sodium (DSS)-induced colitis model. …”
    Get full text
    Article
  10. 7490

    Variant-to-Gene-Mapping Analyses Reveal a Role for the Hypothalamus in Genetic Susceptibility to Inflammatory Bowel DiseaseSummary by Chiara Lasconi, Matthew C. Pahl, Diana L. Cousminer, Claudia A. Doege, Alessandra Chesi, Kenyaita M. Hodge, Michelle E. Leonard, Sumei Lu, Matthew E. Johnson, Chun Su, Reza K. Hammond, James A. Pippin, Natalie A. Terry, Louis R. Ghanem, Rudolph L. Leibel, Andrew D. Wells, Struan F.A. Grant

    Published 2021-01-01
    “…Results: We found significant genetic correlations (rg) of 0.122 with an adjusted P (Padj) = 1.4 × 10-4 for IBD: rg = 0.122; Padj = 2.5 × 10-3 for ulcerative colitis and genetic correlation (rg) = 0.094; Padj = 2.5 × 10-3 for Crohn’s disease, and significant approximately 4-fold (P = .005) and approximately 7-fold (P = .03) enrichment of IBD single-nucleotide polymorphisms in HNs and colonoids, respectively. …”
    Get full text
    Article
  11. 7491
  12. 7492

    Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bowel Disease via Circulating Metabolites: A Mediation Mendelian Randomization Study by Xiaojing Jia, Chunyan Hu, Xueyan Wu, Hongyan Qi, Lin Lin, Min Xu, Yu Xu, Tiange Wang, Zhiyun Zhao, Yuhong Chen, Mian Li, Ruizhi Zheng, Hong Lin, Shuangyuan Wang, Weiqing Wang, Yufang Bi, Jie Zheng, Jieli Lu

    Published 2023-09-01
    “…We applied two-sample Mendelian randomization (MR) to disentangle the effects of omega-3 PUFAs (including total omega-3, α-linolenic acid, eicosapentaenoic acid (EPA), or docosahexaenoic acid (DHA)) on the risk of IBD, Crohn’s disease (CD) and ulcerative colitis (UC). …”
    Get full text
    Article
  13. 7493

    Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study by Carol A Hitchon, Charles N Bernstein, Ruth Ann Marrie, John Kim, Sheila F O’Brien, Christine Mesa, Catherine Card

    Published 2023-05-01
    “…Objective Among persons with immune-mediated inflammatory diseases (IMIDs) who received SARS-CoV-2 vaccines, we compared postvaccine antibody responses and IMID disease activity/states.Design Single-centre prospective cohort study.Setting Specialty ambulatory clinics in central Canada.Participants People with inflammatory arthritis (n=78; 77% rheumatoid arthritis), systemic autoimmune rheumatic diseases (n=84; 57% lupus), inflammatory bowel disease (n=93; 43% Crohn’s) and multiple sclerosis (n=72; 71% relapsing-remitting) (female 79.4%, white 84.7%, mean (SD) age 56.0 (14.3) years) received COVID-19 vaccinations between March 2021 and September 2022.Primary outcome Postvaccination anti-spike, anti-receptor binding domain (anti-RBD) and anti-nucleocapsid (anti-NC) IgG antibodies tested by multiplex immunoassays compared across vaccine regimens and with responses in 370 age-matched and sex-matched vaccinated controls.Secondary outcomes COVID-19 infection and self-reported IMID disease activity/state.Results Most (216/327, 66.1%) received homologous messenger RNA (mRNA) (BNT162b2 or mRNA1273) vaccines, 2.4% received homologous ChAdOx1 and 30.6% received heterologous vaccines (23.9% ChAdOx1/mRNA, 6.4% heterologous mRNA) for their first two vaccines (V1, V2). …”
    Get full text
    Article
  14. 7494

    Registro Nacional de la Nutrición Parenteral Domiciliaria del año 2003 by J. M. Moreno, M. Planas, A. I. de Cos, N. Virgili, P. Gómez-Enterría, J. Ordóñez, C. de la Cuerda, E. Martí, A. Apezetxea, M. T. Forga, A. Pérez de la Cruz, A. Muñoz, A. Rodríguez, D. Cardona, C. Pedrón, L. M. Luengo, C. Garde, R. M. Parés

    “…Las enfermedades que motivaron el uso de NPD fueron la enfermedad neoplásica (21%), seguida de la isquemia mesentérica (20%), enteritis rádica (16,3%), alteraciones de la motilidad (10,5%) y enfermedad de Crohn (4,6%). Se emplearon catéteres tunelizados en el 66,3% de los casos, frente al 29,1% de reservorios subcutáneos. …”
    Get full text
    Article
  15. 7495

    Activation of Nod2 signaling upon norovirus infection enhances antiviral immunity and susceptibility to colitis by Ghaffar Muharram, Marion Thépaut, Pierre-Emmanuel Lobert, Teddy Grandjean, Olivier Boulard, Myriam Delacre, Emmrich Wakeford, Richard Wheeler, Lionel Franz Poulin, Ivo Gomperts Boneca, Frank Lafont, Marie-Cécile Michallet, Didier Hober, Ken Cadwell, Mathias Chamaillard

    Published 2023-12-01
    “…Hence, our results uncover a previously unidentified virus-host-bacterial interplay that may represent a novel therapeutic target for treating noroviral origin gastroenteritis that may be linked with susceptibility to several common illnesses such as Crohn’s disease.…”
    Get full text
    Article
  16. 7496

    Evaluation of the use of glucocorticosteroids by athletes in Poland in the light of the amended anti-doping regulations by Andrzej Pokrywka, Daria Berezovska, Sylwia Lewandowska-Pachecka, Michał Rynkowski, Raphael Faiss, Jarosław Krzywański

    Published 2022-03-01
    “…The basic indications for the use of drugs declared by athletes during doping control are bronchial asthma (57% of cases), rhinitis (26%), pain blockade (7%), inflammatory skin diseases (5.5%), Achilles tendinitis (1.5%), Crohn's disease (1.5%), eye infections (1%), and Addison's Disease (0,5%). …”
    Get full text
    Article
  17. 7497

    RELATO DE CASO: LINFOMA MALT DE CECO by TS Hahn, VT Almeida, AH Schuck, LV Calderan, EW Silva, LM Lorenzini, BK Losch, MFL Pezzi, RD Lorandi

    Published 2023-10-01
    “…Essa patologia pode estar associada a várias outras afecções, principalmente as que alteram o sistema imunológico como o HIV, retocolite ulcerativa, doença de Crohn e doença celíaca. Para fazer a distinção entre linfomas primários do cólon e aqueles com envolvimento secundário utilizam-se os Critérios de Dawson, que consistem em: radiografia de tórax normal, ausência de hepatoesplenomegalia ou linfadenopatia superficial, leucograma normal (sem evidências de processo leucêmico) e massa tumoral intestinal com linfadenopatia exclusivamente regional. …”
    Get full text
    Article
  18. 7498

    Constructing a prediction model of inflammatory bowel disease recurrence based on factors affecting the quality of life by Maojuan Li, Maojuan Li, Yan Tao, Yan Tao, Yang Sun, Yang Sun, Jing Wu, Jing Wu, Fengrui Zhang, Fengrui Zhang, Yunling Wen, Yunling Wen, Min Gong, Min Gong, Jingxian Yan, Jingxian Yan, Hao Liang, Hao Liang, Xinyu Bai, Xinyu Bai, Junkun Niu, Junkun Niu, Yinglei Miao, Yinglei Miao

    Published 2023-03-01
    “…Disease activity, EIMs, and occupational stress were important factors influencing the IBDQ scores of patients with Crohn's disease, and they accounted for approximately 75.1% of the factors affecting the quality of life. …”
    Get full text
    Article
  19. 7499

    MANIFESTAÇÕES CLÍNICAS E LABORATORIAIS DOS PACIENTES COM DEFICIÊNCIA DE VITAMINA B12 ACOMPANHADOS EM HOSPITAL TERCIÁRIO DO RIO DE JANEIRO by CR Berto, KG Frigotto, GSB Garcia, VRA Valviesse, LL Bergier

    Published 2021-10-01
    “…Outras etiologias observadas foram: doença celíaca (10%), abuso de inibidor de bomba de prótons (5%), doença de Crohn (5%), pancreatite recorrente (5%), pólipos gástricos (5%), gastrectomia (5%), e colite infecciosa (5%). …”
    Get full text
    Article
  20. 7500

    Efficacy and Safety in the Continued Treatment With a Biosimilar Drug in Patients Receiving Infliximab: A Systematic Review in the Context of Decision-Making From a Latin-American... by Edward Mezones-Holguin, Rocio Violeta Gamboa-Cardenas, Gadwyn Sanchez-Felix, José Chávez-Corrales, Luis Miguel Helguero-Santin, Luis Max Laban Seminario, Paula Alejandra Burela-Prado, Maribel Marilu Castro-Reyes, Fabian Fiestas

    Published 2019-11-01
    “…In the Peruvian Social Security (EsSalud), infliximab is approved for the treatment of rheumatoid arthritis, psoriasis, psoriatic arthropathy, ankylosing spondylitis, ulcerative colitis and Crohn’s disease (in cases refractory to conventional treatment). …”
    Get full text
    Article